Can Artificial Intelligence Predict Cancer Vulnerability from Biopsies for Precision Oncology?
A recent study in the Journal of Clinical Oncology reveals a groundbreaking artificial intelligence (AI) tool, ‘DeepHRD‘, that can predict how vulnerable a cancer is to platinum-based chemotherapy using routine histopathology slides. This development, led by scientists at the University of California, San Diego, could drastically improve cancer treatment and bring faster, more accurate care…
